Longeveron Inc.
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial (NCT02587572) | Longeveron Inc. | 2023-12-01 |
| Lomecel-B Effects on Alzheimer's Disease (NCT05233774) | Longeveron Inc. | 2021-12-28 |
| Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. (NCT04925024) | Longeveron Inc. | 2021-06-25 |
| Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER) (NCT04629105) | Longeveron Inc. | 2020-07-24 |
| Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) (NCT03525418) | Longeveron Inc. | 2018-02-21 |
Track Longeveron Inc. automatically
Every clearance here is in the API, with alerts when new ones post.